Researchers at the Paul Scherrer Institute PSI have tested various methods to check how effective they are in combatting certain types of cancer. They found a combination of two preparations to be much more effective than treatment with just one of the two active substances. This is particularly important for the treatment of modular thyroid carcinomas. If the results obtained so far are confirmed in future studies, this therapy could be available to the general public in a few years.
Martin Béhé (left), head of the Pharmacology Group at the Centre for Radiopharmaceutical Sciences and his colleague Michal Grzmil are very pleased with the positive results of the study.